Publications by authors named "Sean Stern"

Claim this Profile
N
New onset of comorbidities in people with epilepsy in a national healthcare claims database.
Edward Faught, Emily Klatte, Clarence T Wade, Sean Stern, Wesley T Kerr

Seizure· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States.
Gregory S Connor, David M Labiner, Vernon F Schabert, Mindl Weingarten, Clarence T Wade, Sean Stern

Epilepsy Behav· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
Rebecca O'Dwyer, Sean Stern, Clarence T Wade, Anuradha Guggilam, William E Rosenfeld

Drugs Aging· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive and psychiatric adverse events during adjunctive cenobamate treatment in phase 2 and phase 3 clinical studies.
Gregory L Krauss, Steve S Chung, Louis Ferrari, Sean Stern, William E Rosenfeld

Epilepsy Behav· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
Sami Aboumatar, Louis Ferrari, Sean Stern, Clarence T Wade, Mindl Weingarten

Epilepsy Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
Sean Stern, Mindl Weingarten, Sudhakar Mandapati, Louis Ferrari, Clarence T Wade

Epilepsy Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
David G Vossler, William E Rosenfeld, Sean Stern, Clarence T Wade, Louis Ferrari

Epilepsia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Vernon F Schabert, Sean Stern, Louis Ferrari, Clarence T Wade, Richard J Willke

Epilepsy Behav· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.
James P Hummel, Robert J Leipold, Stacey L Amorosi, Haikun Bao, Kristen A Deger, Sean Stern

J Cardiovasc Electrophysiol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation.
Sean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, Fernando Camacho, Elham Rahme

J Med Econ· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.
Michael L Ganz, Sean Stern, Alex Ward, Luba Nalysnyk, Martin Selzer

Orphanet J Rare Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
Jörg Tomeczkowski, Sean Stern, Alfred Müller, Christian von Heymann

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands.
Floortje van Nooten, Sean Stern, Gert-Jan Braunstahl, Chris Thompson, Martijn Groot

J Med Econ· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales.
Ruth E Brown, Sean Stern, Sujith Dhanasiri, Steve Schey

Eur J Health Econ· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a FISH assay for the diagnosis of melanoma in the USA.
Anuraag R Kansal, Alissa J Shaul, Sean Stern, Klaus Busam, Cynthia A Doucet

Expert Rev Pharmacoecon Outcomes Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.
Mark A Turco, Anuraag R Kansal, Sean Stern, Stacey L Amorosi, Paul L Underwood

J Interv Cardiol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis